Position in DYN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,573,100
-$269,722 QoQ
Shares Held
746,200
-19.7% QoQ
Ownership
0.400%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 245 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. DYN ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,573,100 | 746,200 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $16,842,822 | 929,003 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $23,737,212 | 1,213,559 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $17,950,434 | 1,419,007 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $12,967,912 | 1,362,176 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $14,555,997 | 1,391,587 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,754,648 | 753,593 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $37,833,167 | 1,053,262 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $19,728,940 | 559,052 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $27,315,832 | 962,164 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $26,884,551 | 2,021,395 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $965,364 | 107,742 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,292,004 | 114,845 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,309,014 | 113,630 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $746,740 | 64,430 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,645,154 | 129,540 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,566,699 | 228,050 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,935,793 | 304,543 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $4,445,907 | 373,920 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,685,351 | 103,778 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $97,960 | 4,656 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,956 | 126 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $509,775 | 24,275 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||